Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921

Erica Brivio, Edoardo Pennesi, Marieke E. Willemse, Alwin D.R. Huitema, Yilin Jiang, Harm D.R. Van Tinteren, Vincent H.J. Van Der Velden, Berna H. Beverloo, Monique L. Den Boer, Lukas A.J. Rammeloo, Chad Hudson, Nyla Heerema, Karey Kowalski, Huadong Zhao, Luke Kuttschreuter, Francisco J. Bautista Sirvent, Andrew Bukowinski, Carmelo Rizzari, Jessica Pollard, Laura Murillo-SanjuánMatthew Kutny, Sara Zarnegar-Lumley, Michele Redell, Stacy Cooper, Yves Bertrand, Arnaud Petit, Julie Krystal, Markus Metzler, Donna Lancaster, Jean Pierre Bourquin, Jayashree Motwani, Inge M. Van Der Sluis, Franco Locatelli, Michael E. Roth, Nobuko Hijiya, Christian M. Zwaan*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)
10 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science